Paul McCormac

Insider Reports History

Location
New York, NY
Signature
/s/ Jenny Robertson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul McCormac:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Technical Officer Common Stock 17,349 $190,839 $11.00 07 Nov 2023 Direct
Lexeo Therapeutics, Inc. Chief Technical Officer Series B convertible preferred stock 0 07 Nov 2023 Direct

Insider Reports Filed by Paul McCormac

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXEO Lexeo Therapeutics, Inc. 07 Nov 2023 2 $0 4 Chief Technical Officer 09 Nov 2023, 20:35
LXEO Lexeo Therapeutics, Inc. 02 Nov 2023 0 $0 3 Chief Technical Officer 02 Nov 2023, 21:38